Literature DB >> 2992650

Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors.

P J Leigh, J MacDermot.   

Abstract

The binding of [3H]-iloprost (ZK36374) to NCB-20 membranes revealed a single population of high affinity receptors (KD = 9.55 nM, Bmax = 431 fmol mg-1 protein) and a low affinity, non-saturable binding component. Desensitization of prostacyclin-responsiveness of NCB-20 cells is induced by culture in the presence of the stable prostacyclin analogue carbacyclin. Desensitization is accompanied by an increase in the Kact value for prostacyclin (64.1 nM to 175 nM), and a reduction in the prostacyclin-dependent increase in adenylate cyclase activity (41.2 to 15.1 pmol cyclic AMP min-1 mg-1 protein). Desensitization is not accompanied by changes in the coupling of the catalytic (C) to the regulatory (Ns) subunit of adenylate cyclase. In addition, the physical identity of the receptor molecule (as characterized by its sensitivity to electron bombardment in the beam of a linear accelerator) is not changed by desensitization. Desensitization of prostacyclin-dependent activation of adenylate cyclase may be explained most simply by a loss of prostacyclin receptors. The anomalous increase in the Kact (concentration of prostaglandin giving half-maximum enzyme activation) for prostacyclin-stimulated adenylate cyclase was not accompanied by a substantial change in the KD of [3H]-iloprost binding, and is explained by a loss of spare receptors. Prostacyclin responsiveness in non-dividing cells may be restored after desensitization by prolonged culture (up to 48 h) in the absence of carbacyclin. Resensitization is accompanied by restoration of the high affinity Kact value (143 nM to 45.5 nM), and is dependent on de novo protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992650      PMCID: PMC1916758          DOI: 10.1111/j.1476-5381.1985.tb08852.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Effect of PGI2 and stable endoperoxide analogues on cyclic nucleotide levels in clonal cell lines of CNS origin.

Authors:  R Ortmann
Journal:  FEBS Lett       Date:  1978-06-15       Impact factor: 4.124

2.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

3.  Further evidence that desensitization of beta-adrenergic-sensitive adenylate cyclase proceeds in two steps. Modification of the coupling and loss of beta-adrenergic receptors.

Authors:  V Homburger; M Lucas; B Cantau; J Barabe; J Penit; J Bockaert
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

4.  Prostaglandin I2 receptors in a particulate fraction of platelets of various species.

Authors:  E Schillinger; G Prior
Journal:  Biochem Pharmacol       Date:  1980-09-01       Impact factor: 5.858

5.  Prostacyclin-dependent activation of adenylate cyclase in a neuronal somatic cell hybrid: prostanoid structure-activity relationships.

Authors:  I A Blair; C N Hensby; J MacDermot
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

6.  Prostaglandin profiles in tissue and blood vessels from human brain.

Authors:  M S Abdel-Halim; H von Holst; B Meyerson; C Sachs; E Anggård
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

7.  Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.

Authors:  O V Miller; R R Gorman
Journal:  J Pharmacol Exp Ther       Date:  1979-07       Impact factor: 4.030

8.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

9.  Agonist-specific desensitization of PGI2-stimulated cyclic AMP accumulation by PGE1 in human foreskin fibroblasts.

Authors:  R R Gorman; N K Hopkins
Journal:  Prostaglandins       Date:  1980-01

10.  Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?

Authors:  H Sinzinger; K Silberbauer; A K Horsch; A Gall
Journal:  Prostaglandins       Date:  1981-01
View more
  6 in total

1.  Internalization and down-regulation of the prostacyclin receptor in human platelets.

Authors:  S Giovanazzi; M R Accomazzo; O Letari; D Oliva; S Nicosia
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Desensitization of iloprost responsiveness in human platelets follows prolonged exposure to iloprost in vitro.

Authors:  U Alt; P J Leigh; A J Wilkins; P K Morris; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

3.  Segregation of discrete GS alpha-mediated responses that accompany homologous or heterologous desensitization in two related somatic hybrids.

Authors:  E Kelly; M Keen; P Nobbs; J MacDermot
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

4.  Electrophysiological study of SR 42641, a novel aminopyridazine derivative of GABA: antagonist properties and receptor selectivity of GABAA versus GABAB responses.

Authors:  M Desarmenien; E Desaulles; P Feltz; M Hamann
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

5.  Prostacyclin analogues reduce ADP-ribosylation of the alpha-subunit of the regulatory Gs-protein and diminish adenosine (A2) responsiveness of platelets.

Authors:  R J Edwards; J MacDermot; A J Wilkins
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

6.  Agonist-dependent internalization and trafficking of the human prostacyclin receptor: a direct role for Rab5a GTPase.

Authors:  Martina B O'Keeffe; Helen M Reid; B Therese Kinsella
Journal:  Biochim Biophys Acta       Date:  2008-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.